Research Updates

It looks like Dr. Picozzi and Dr. Laheru have been busy. A study using a variant of Picozzi's protocol (Gemcitabine instead of 5FU, with Cisplatin and Interferon) has shown very good results for adjuvant therapy (44% 4-year OS). Laheru has also published updated results that show a median survival of 26 months from the phase II study of the Hopkins vaccine. I think this wasn't as promising as I was hoping (although I'm not sure I understand the numbers fully) but it still seems to be significant.